The present disclosure relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of the FGFR3 and/or FGFR4 enzyme and are useful in the treatment of FGFR-associated diseases.
本公开涉及双环
杂环化合物及其药物组合物,这些化合物是FGFR3和/或FGFR4酶的
抑制剂,可用于治疗与FGFR相关的疾病。